Dear Providers:
FirstCarolinaCare Insurance Company, Inc. (“FirstCarolinaCare”) is pleased to offer you the second edition of Provider Points . The purpose of the newsletter is to offer you timely, useful and actionable information that will be of benefit to you and your patients who are enrolled in FirstCarolinaCare plans.
First, I would like to introduce myself to those who may not know me. I am the Provider Relations Manager at FirstCarolinaCare. I have been with FirstCarolinaCare since it began in 1998. My background includes hospital finance with Hospital Corporation of America for four years, physician practice management for nine years and, finally, managed care since 1998. I have seen the health care system from all sides, which helps me to be responsive to the concerns and needs of our participating providers.
Since its inception, FirstCarolinaCare has strived to be a “provider friendly” health plan by trying to make interactions with us as simple as possible. In fact, 95 percent of office managers surveyed in 2006 said they were either completely satisfied or very satisfied with FirstCarolinaCare. Currently, more than 60 percent of claims are submitted electronically, and we are always trying to increase that percentage. This enables us to process claims more quickly and accurately, which results in your having your payment faster. We also continue to work with clinics in setting up electronic remittances so information is posted electronically to the patient’s account, resulting in more efficiency in your practice. FirstCarolinaCare pays 91 percent of all claims within 14 days of receipt and has an accuracy rate of 99 percent in processing claims. This achievement also creates efficiency in your practice by eliminating the need for followup phone calls by your staff. If you have an interest in learning more about electronic submission of claims or electronic remittance, please call me at (910) 715-8115.
FirstCarolinaCare’s continued success depends on an active and positive relationship with the providers in our community. If you have any questions, feedback or suggestions, please call me at (910) 715-8115 or e-mail me at bjadcock@firstcarolinacare.com.
Sincerely,
Barbara Adcock
Provider Relations Manager
|
|
back to top |
Did You Know? |
• |
Effective July 1, 2007, FirstCarolinaCare began covering annual screening mammograms for all women over 40, following the
latest recommendations of the American Cancer Society. (N.C. state law mandates every other year for women aged 40 to 49) |
• |
An annual eye examination is covered for all members with diabetes. The claim for the exam should be filed with ICD-9 code
reflective of diabetes to ensure correct processing |
|
* |
Consistent with our mission to ensure that our insured patients receive the highest quality care, we ask that you make an effort to be sure
that your diabetic patients who have not yet had an eye exam this year get one before the year ends. |
• |
FirstCarolinaCare now has 12,701 members; only 5,454 are FirstHealth of the Carolinas employees and dependents. |
• |
FirstCarolinaCare covers Prilosec OTC and Claritin/Claritin D with a prescription at the generic copayment level. |
• |
Precertification is no longer required for RAST testing for 10 or fewer tests. |
back to top |
 |
| Pharmacy Corner |
| Tablet-Splitting Program Expands to Include More Medications |
| On September 1, 2007, FirstCarolinaCare Insurance Company Inc. (FCC) expanded
the physician requested tablet-splitting program, “Split the Pill, Split Your Bill,” to include more medications to help members save 50 percent on their monthly copayments. |
New Additions to Tablet-
Splitting Program |
Potential Patient
Savings Each Year |
Lexapro 5mg, 10mg, 20mg
|
$240-$300 |
Lamictal 25mg, 100mg, 150mg, 200mg |
$150-$210 |
Benicar 20mg, 40mg |
$150-$210 |
Benicar HCT 20/12.5mg, 40/12.5mg, 40/25mg |
$150-$210 |
Pravastatin 80mg |
$60 |
Current Medications in
Tablet-Splitting Program |
Potential Patient
Savings Each Year |
Crestor 5mg, 10mg, 20mg, 40mg
|
$240-$300 |
Lipitor 10mg, 20mg, 40mg, 80mg |
$150-$210 |
Simvastatin 5mg, 10mg, 20mg, 40mg, 80mg |
$60 |
Pravastatin 10mg, 20mg, 40mg |
$60 |
|
If your patient is taking one of the medications above and you believe your patient can
safely split the tablets in half with a tablet splitter, then he or she can save 50 percent each month on the medication.
In order to participate in the tablet-splitting program, your patient will need a newprescription for:
1) Higher Strength Tablet
2) Qty of 15 Tablets (30-day supply)
3) Directions: Take ½ tablet daily
4) Tablet Splitter
The new prescription will allow your patients to get a 30-day supply for 50 percent of their usual copayment. FCC will continue to pay for two tablet splitters a year for patients participating in the tablet-splitting program to safely split their tablets.
If you have any questions about the tablet-splitting program, please contact Elise McInnis at (910) 715-1908.
back to top |
 |
| New Generics in 2007 |
| Brand Name |
Generic Name |
| Ambien |
zolpidem |
| Cipro XR |
ciprofloxacin |
| Coreg |
carvedilol |
| Focalin Immediate Release tablets (QL) * |
dexmethylphenidate tablets |
| Lamisil (QL)* |
terbinafine |
| Lotrel (10/20mg, 5/20mg, 5/10mg, 2.5/10mg) |
amlodipine/benazepril |
| Natafort |
vinatal forte |
| Norvasc |
amlodipine |
| Omnicef |
cefdinir |
| Pravachol 80mg (TS) ** |
pravastatin |
| Toprol XL (25mg, 50mg, 100mg, 200mg) |
metoprolol extended release |
| Vantin |
cefpodoxime |
| Zantac syrup |
ranitidine syrup |
*QL-quantity limit
**TS-tablet splitting opportunity |
|
|
|
|
| • |
In 2005, the FDA mandated the discontinuation of the propellant, chlorofluorocarbon (CFC), by December 31, 2008 due to the
harmful effects on the ozone layer
and to be compliant with the
Montreal Protocol. As a result of this
ruling, albuterol CFC inhalers are
being reformulated to remove the CFC propellant and replacing it with a more environmentally friendly hydrofluoroalkane (HFA) propellant.
At this time, only one pharmaceutical company has continued to manufacture generic albuterol CFC inhalers. As a result, the supply of generic albuterol CFC inhalers has greatly decreased and the availability at the pharmacy may be unpredictable. This will mean that more patients will be transitioning from the albuterol CFC inhalers to the albuterol HFA inhalers before the December 31, 2008 deadline.
The new albuterol HFA inhalers are considered brand medications without generic equivalents according to the FDA. This means the copayment will increase from the generic copayment to the preferred brand copayment. There are three Albuterol HFA inhalers available: ProAir HFA®, Proventil HFA®, and Ventolin HFA®. All three HFA inhalers are preferred brand medications on the FirstCarolinaCare formulary. |
| • |
Omacor changes name to Lovaza at
the request of the FDA. Lovaza will
remain a non-preferred medication
on the FirstCarolinaCare formulary. |
| • |
Biaxin XL, Cipro suspension and Vivelle-Dot patches are no longer available generically. All three medications are preferred on the FirstCarolinaCare formulary. |
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
|
| Pharmacy Benefit Reminders |
FirstCarolinaCare has a mandatory generic policy. This policy applies to brand medications that have generic equivalents. In order for patients to save the most money, the generic equivalent should be prescribed and dispensed. This allows the patient to be charged only the generic copayment. If the provider or patient feels a brand medication is necessary, the patient will pay the applicable copayment plus the cost difference between the brand and generic medication.
The mandatory generic policy does not apply to “Narrow Therapeutic Index” (NTI) medications. According to the North Carolina Board of Pharmacy, NTI medications must be refilled with the same medication from the same manufacturer that was last dispensed unless the pharmacist has permission from the provider and patient to use another manufacturer. For NTI medications, the member will pay only the applicable copayment.
back to top |
Precertification and
FirstCarolinaCare Insurance Company |
By Leonard Newton, M.D., Local Medical Director |
While many people believe that precertification plans are in place at managed care companies solely to reduce utilization, that is generally not the case. It is certainly not the case at FirstCarolinaCare. These programs began in response to major geographic and practice variation that could not be explained on any clinical basis. Reports of hysterectomy rates differing severalfold between states and cardiovascular surgery rates that were triple in one city as compared to a neighboring city pushed managed-care companies to incorporate processes to ensure serviceswere provided based on generally accepted clinical criteria.
At FirstCarolinaCare, we work to help our members get what they need, when they need it, in a cost-effective manner and, most importantly, through the application of evidence-based clinical pathways. FirstCarolinaCare believes that providing evidencebased care can improve outcomes and reduce costs, ultimately decreasing the rate of premium growth. This helps keep premiums more affordable for employers so they can continue to offer health insurance to their employees – thus slowing the rate of growth of the uninsured population.
For precertification purposes, FirstCarolinaCare uses InterQual (IQ) criteria. These nationally recognized criteria provide clinical guidelines and information that help determine the appropriateness of proposed services. The criteria are used to approve care, not deny it. They are based on analysis of well-researched medical studies and are updated annually. Prior to the release of criteria, clinical consultants who have not been part of the initial review process assess and validate the criteria content for clinical accuracy. When practice patterns suggest there may be a variation in the local standard of care, FirstCarolinaCare has a process for additional review. The IQ criteria in question are reviewed first by our medical directors and then by the medical management committee, FirstQIC. Practicing physicians serving on FirstQIC review the literature and the criteria, and can make appropriate recommendations to FirstCarolinaCare. Through this process, several sets of criteria were either created or modified to reflect local physician input within the last year.
The precertification process begins with a call or fax to FirstCarolinaCare precertification nurses. These nurses are educated and trained in the use of IQ criteria and in the collection of pertinent information to apply those criteria. The nurses never deny a request for any service. They either approve it if it meets the IQ criteria, or refer it to a medical director for review. The vast majority of precertification requests are approved by the nurses, and the majority of those sent to physician reviewers are also approved.
Denials overwhelmingly occur because insufficient clinical information is provided by the requestor, generally the provider’s office. Other common causes for denials include a lack of trial of conservative management, a lack of trial of less invasive, less costly testing, and sometimes because a more expensive test such as MRI may be more definitive or more appropriate than a less expensive tests such as a CT scan.
Once a request for services is approved or denied, letters are sent to the member and the requesting provider. Nonapproval letters outline the reason for the denial, as well as the appeals procedures required by North Carolina law. However, since the most common cause for denial is inadequate information, if additional information is available, contacting the precertification nurses with that information may be the most appropriate and efficient response to a non-approval letter. Additionally, if desired, the precertification nurse can arrange for a peer-to-peer conversation with the medical director on call.
In summary, precertification is used by FirstCarolinaCare to increase the value our members receive for their premium dollars, and to encourage the practice of evidence-based medicine and clinical pathways executed through the use of clinical criteria.
back to top |
FirstCarolinaCare Insurance Company, Inc. is a
wholly-owned subsidiary of FirstHealth of the Carolinas. |
|
|